Use of herbal medicine among pregnant women referring to Valiasr Hospital in Kazeroon, Fars, South of Iran

Journal of Medicinal Plants

Volumn 10, Issue 37, 2011, Pages 96-108

  Tabatabaee, M ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Herbal medicine; Pregnancy

Indexed keywords

CHAMOMILE; HERBACEOUS AGENT; PEPPERMINT;

ADULT; AMMI VISNAGA; ARTICLE; BARBERRY; BASIL; BORAGO; CINNAMON; CLOVE; CUMIN; DIET SUPPLEMENTATION; DRUG UTILIZATION; FAMILY; FEMALE; FIRST TRIMESTER PREGNANCY; FLIXWELD; GINGER; GLYCYRRHIZA; HERB; HUMAN; IRAN; JUJUBE; MAIDENHAIR; MAJOR CLINICAL STUDY; OLIBANUM; PREGNANT WOMAN; RISK BENEFIT ANALYSIS; SAATAR; SAFFRON; SOUR ORANGE; TERATOGENICITY;

AMMI; OCIMUM BASILICUM;

EID: 79960650417     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Physicians' Desk Reference (PDR) for herbal medicines, Thomson PDR, Montvale, USA 2004.
2. Ernst E. Risk associated with complementary therapies In: Dukes MNG, Aronson JK (eds) Meylers. Side - Effects of Drugs, 14 th edn.Elsevier, Amsterdam. 2000, pp: 1649.
3. Ramawat K.J. Herbal Drugs: Ethnomedicine to Modern Medicine. 2009, pp: 382.
4. Pinn G. Aust Fam Phys. 2001, pp: 30-5.
5. Eisenberg DM, Davis RB, Ettner S, Apple S. Wilkey S, Rompay MV et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998; 280: 1569-75.
6. Kuo GM, Hawley ST, Weiss LT, Balkrishnan R, Volk RJ. BMC. Complement Altern Med. 2004; 4: 18.
7. Gardiner P, Graham R, Legedza AT, Ahn AC, Eisenberg DM Philips RS. Altern Ther. Health Med. 2007; 13: 22.
8. Goldstein LH, Elias M, Ron-Avraham G, Biniaurishvili BZ, Madjar M, Kamargash I, Braunstein R, Berkovitch M, Golik A. Br. J. Clin. Pharmacol. 2007; 64: 373.
9. Cuzzolin L, Zaffani S, Murgia V, Gangemi M, Meneghelli G, Chiamenti GP, Benoni G. Eur. J. Pediatr. 2003; 162: 820.
10. Conover EA. Best Pract Res. Clin Endocrinol Metab. 2003; 17: 237.
11. Sibinga E, Ottolini M, Duggan A, Wilson M. Pediatr Res. 2000; 47: 226.
12. Mabina MH, Pitsoe SB, Moodley J. Trop Doct. 1997; 27: 84.
13. Gibson PS, Powrie R, Star J. Obstet Gynecol. 2001; 97: S44.
14. Tsui B, Dennehy C, Tsourounis C: A survey of dietary supplement use during pregnancy at an academic medical center. Am. J Obs. Gyn. 2001; 185: 433-7. (Pubitemid 32769447)
15. Hepner DL, Harnett M, Segal, S, Camann W, Bader AM, Tsen LC. Herbal Medicine Use in Parturients. Anesth Analg. 2002; 94 (3): 690-3.
16. Glover GD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over-the-counter and herbal medicine use in a rural, obstetric population. Am. J. Obstet Gynecol. 2003; 188: 1039-45.
17. Ernst E, White A. The BBC survey of complementary medicine use in the UK. Compl. Ther. Med. 2000; 8: 32-6.
18. Astin JA. Why patients use alternative medicine? Results of a national study. J. Am. Med. Ass. 1998; 279: 1548-53.
19. Westfall RE. Herbal healing in pregnancy: women's experiences. J. Herb Pharmacother. 2003; 3: 17-39. (Pubitemid 38035275)
20. M. Baccini, L. Cuzzolin, T. Camerlengo, G. Velo and G. Benoni, Phytotherapic compounds. The consumer-pharmacist relationship. Drug Saf. 2008; 31: 424-7.
21. Adams C, Cannell S. Menopause. 2001; 8: 433.
22. Mabina MH, Pitsoe SB, Moodley J.: The effect of traditional herbal medicines on pregnancy outcome. S. Afr. Med. J. 1997; 87: 1008-10.
23. Maats F, Crowther C: Patterns of vitamin, mineral and herbal supplement use prior to and during pregnancy. Aust. N. Z. J. Obs Gyn. 2002; 42: 494-6.
24. Ernst E. Herbal medicinal products during pregnancy: are they safe?. Brit. J. Obs. Gyn. 2002; 109: 227-35.
25. Lacroix I, Damase-Michael C, Lapeyre-Mestre M, Montastrue JL. Prescription drugs during pregnancy in France. Lancet. 2000; 356: 1735-6.
26. Pakrashi A, Bhattacharya N. Abortifacient principle of Achyranthes asperaLinn. Indian J. Exp. Biol. 1977 Oct; 15 (10): 856-8.
27. Seely D, Dugoua JJ, Perri D, Mills E, Koren G. Safety and efficacy of panax ginseng during pregnancy and lactation. Can J Clin Pharmacol. 2008 Winter; 15 (1): e87-94 Epub 2008 Jan 18.
28. Dugoua JJ, Perri D, Seely D, Mills E, Koren G. Safety and efficacy of blue cohosh (Caulophyllum thalictroides) during pregnancy and lactation. Can. J. Clin. Pharmacol. 2008 Winter; 15 (1): e66-73. Epub 2008 Jan 18.
29. Goel RK, Prabha T, Kumar MM, Dorababu M, Prakash, Singh G. Teratogenicity of Asparagus racemosus Willd. root, a herbal medicine. Indian J. Exp. Biol. 2006 Jul; 44 (7): 570-3.
30. A. Vickers and C. Zollman, ABC of complementary medicine. Herbal medicine. BMJ. 1999; 319: 1050-3.
31. Sereshti M, Azari P., Rafieian M, Kheyri S. Use of herbal medicines by pregnant women in Shahr-e-Kord. J. Repro. Infert. 2006 Summer; 7 (3): 125-131. (Persian)
32. Nordeng H, Havnen G. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiology and drug safety. 2004; 13: 371-80. (Pubitemid 38787156)
33. Forster DA, Denning A, Wills G, Bolger M, McCarthy E. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy Childbirth. 2006; 6: 21.
34. Paul S, Raymond P, Jami S. Herbal and alternative medicine use during pregnancy: a cross-sectional survey. Obstet Gynecol. 2001; 17: SS44-SS45.
35. Hemminki E, Mantyranta T, Malin M, Koponen P. A survey on the use of alternative drugs during pregnancy. Scand. J. Soc. Med. 1991; 19: 199-204.
36. Moussally K, Oraichi D, Berard A. Herbal product use during pregnancy: prevalence and predictors. Pharmacoepidemiology and Drug Safety. 2009; 18: 454-61.
37. Natural Standard Research Collaboration. Chamomile (Matricaria recutita, Chamaemelum nobile). MedlinePlus, a service of the U. S. national library of medicine and the national institutes of health 2007.
38. Wilkinson JM. What do we know about herbal morning sickness treatments? A literature survey. Midwifery 2000; 16: 224-8.
39. rd edn.), Pharmaceutical press, London - Chicago (2007).
40. Byrne M, Semple S, Coulthard K. Complementary medicine use during pregnancy. Australian Pharmacist 2002, 21: 954-9.
41. Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J. Clin. Pharm. Ther. 2002; 27: 391-401.
42. Nordeng H, Havnen GC. Impact of socio-demographic factors, knowledge and attitude on the use of herbal drugs in pregnancy. Acta Obstet Gynecol. Scand. 2005; 84: 26-33.
43. Aasland OG, Borchgrevink CF, Fugleli P. Norwegian physicians and alternative medicine. Knowledge, attitudes and experiences. Tidsskr Nor. Lægeforen. 1997; 17: 2464-8.
44. Wharton R, Lewith G. Complementary medicine and the general practitioner. Br. Med. J. (Clin. Res. Ed). 1986; 292: 1498-500.
45. Visser GJ, Peters L. Alternative medicine and general practitioners in The Netherlands: towards acceptance and integration. Fam. Pract. 1990; 7: 227-32.
46. Einarson A, Lawrimore T, Brand P, Gallo M, Rotatone C, Koren G. Attitudes and practices of physicians and naturopathstoward herbal products, including use during pregnancy and lactation. Can. J. Clin. Pharmacol. 2000; 7: 45-9.
47. MacLennan AH, Myers SP, Taylor AW: The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. MJA. 2006, 184: 27-31.